Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Terminated 2Withdrawn 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1

Conditions

Radiodermatitis 3Head and Neck Neoplasms 3Hypotension 2Stroke 1Shock, Septic 1Optimal Tissue Perfusion 1Neoplasms 1Mouth Neoplasms 1Brain Neoplasms 1Alopecia 1

Interventions

Low-Level Light Therapy 6Standard of Care 5Petrolatum 3Norepinephrine 3triethanolamine 2sapropterin 2Sodium Chloride 2Radiotherapy 2Curcumin 2Biafine 2eucerin 1epigallocatechin gallate 1dimethicone 1cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1calcipotriene 1Zinc Oxide 1Triamcinolone Acetonide 1Thioctic Acid 1Sodium Hypochlorite 1Silver Sulfadiazine 1Radiotherapy, Conformal 1Practice Guidelines as Topic 1Melatonin 1Laser Therapy 1Hydrogel, Polyethylene Glycol Dimethacrylate 1Hydrocortisone 1Gels 1Dimethyl Sulfoxide 1Centella asiatica extract 1Catechin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Radiodermatitis × Norepinephrine × Clear all
NCT01263366 2013-04-19

Exploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer Patients

ProCertus BioPharm, Inc

Phase 1 Terminated
10 enrolled

Radiodermatitis

NCT01544504 2012-05-28

Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy

ProCertus BioPharm, Inc

Phase 1/2 Withdrawn

Radiodermatitis

NCT01367990 2012-03-23

Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy

ProCertus BioPharm, Inc

Phase 1 Terminated
3 enrolled
Head & Neck

Alopecia, Head and Neck Neoplasms, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡